Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Inventory (2018 - 2025)

Historic Inventory for Kyntra Bio (KYNB) over the last 8 years, with Q3 2025 value amounting to $3.9 million.

  • Kyntra Bio's Inventory fell 8385.76% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 8385.76%. This contributed to the annual value of $3.2 million for FY2024, which is 8162.81% down from last year.
  • Per Kyntra Bio's latest filing, its Inventory stood at $3.9 million for Q3 2025, which was down 8385.76% from $3.9 million recorded in Q2 2025.
  • Kyntra Bio's 5-year Inventory high stood at $43.1 million for Q1 2022, and its period low was $3.2 million during Q4 2024.
  • Moreover, its 5-year median value for Inventory was $27.3 million (2024), whereas its average is $26.4 million.
  • In the last 5 years, Kyntra Bio's Inventory skyrocketed by 14836.91% in 2021 and then tumbled by 8845.8% in 2025.
  • Over the past 5 years, Kyntra Bio's Inventory (Quarter) stood at $31.0 million in 2021, then surged by 30.38% to $40.4 million in 2022, then plummeted by 57.53% to $17.2 million in 2023, then plummeted by 81.63% to $3.2 million in 2024, then increased by 22.47% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $3.9 million for Q2 2025, and $3.2 million during Q1 2025.